Means and Methods to Treat Diabetes
AssigneeEberhard Karls Universitaet Tuebingen Medizinische Fakultaet
InventorsShannon Layland, Katja Schenke-Layland, Garry Duffy, Svenja Hinderer, Aline Zbinden
Life of this patent
Estimating the term…
Abstract
The present application relates to a pharmaceutical composition for use in a method of treating diabetes in a human or animal subject in need thereof, to transplantation devices comprising the pharmaceutical composition of the present invention and to methods of treating diabetes using the pharmaceutical composition and transplantation device of the present invention.
Claims17
A method of treating diabetes in a human or animal subject in need thereof comprising administering an effective amount of a pharmaceutical composition comprising nidogen, a liquid or semiliquid pharmaceutically acceptable carrier and one or more of the cell components selected from the group consisting of:
- pancreatic islets, pancreatic pseudo-islets, pancreatic cells, non-pancreatic insulin producing cells, and pancreatic β-cells;
- wherein the nidogen is present in a concentration from 25 μg/ml to 35 μg/ml in the pharmaceutical composition.
A pharmaceutical composition for use in a method of treating diabetes type in a human or animal subject in need thereof comprising nidogen, a liquid or semiliquid pharmaceutically acceptable carrier and one or more of the cell components selected from the group consisting of:
- pancreatic islets, pancreatic pseudo-islets, pancreatic cells, non-pancreatic insulin producing cells, and pancreatic β-cells, wherein the nidogen is present in a concentration from 25 μg/ml to 35 μg/ml in the pharmaceutical composition.
Dependencies are inferred from the claim text.